CLINICAL_TRIALS
ClinicalTrials.gov record update
Nonmyeloablative BMT With Post-transplant Cyclophosphamide, Rituximab and Optimized Donor Selection for B-cell Lymphomas
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00946023
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:49.497127+00:00
- Published At
- 2018-07-24T00:00:00+00:00
- Record Updated At
- 2018-08-27
- Results Posted At
- 2018-07-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Lymphoma", "B-cell Lymphoma", "Non Hodgkin Lymphoma", "Chronic Lymphocytic Leukemia"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-08-27"- protocolSection.identificationModule.nctId
"NCT00946023"- protocolSection.identificationModule.officialTitle
"Nonmyeloablative BMT With Post-transplant Cyclophosphamide, Rituximab and Optimized Donor Selection for B-cell Lymphomas"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-07-24"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.